UK NICE rules against interferon- and glatiramer acetate in FAD

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1314, 2001-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on UK NICE interferon- /glatiramer acetate appraisal

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 298, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

UK NICE issues guidance on interferon- , glatiramer acetate for MS

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Glatiramer acetate blocks the activation of THP-1 cells by interferon-

By Li Q. Milo R. Panitch H. Swoveland P. Bever C.T.

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 303-310

Elsevier

Access to resources Recommend Favorite

Azathioprine/glatiramer acetate/interferon--1a: Rapid progression of myelodysplastic syndrome to acute myeloid leukaemia (first report with glatiramer acetate): case report

Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Glatiramer acetate/interferon-β-1b: Anaphylaxis, then depression with aggression and irritability: case report

Reactions Weekly, Vol. 1, Iss. 1414, 2012-01 ,pp. : 27-28

Adis International

Access to resources Recommend Favorite